Early Detection and Diagnosis

You have full text access to this OnlineOpen article

UDP-N-acetyl-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 6 (ppGalNAc-T6) mRNA as a potential new marker for detection of bone marrow-disseminated breast cancer cells

  1. Teresa Freire1,†,
  2. Nora Berois1,
  3. Cecilia Sóñora1,
  4. Mario Varangot2,
  5. Enrique Barrios3,
  6. Eduardo Osinaga3,‡,*

Article first published online: 4 APR 2006

DOI: 10.1002/ijc.21959

Issue

International Journal of Cancer

International Journal of Cancer

Volume 119, Issue 6, pages 1383–1388, 15 September 2006

Additional Information

How to Cite

Freire, T., Berois, N., Sóñora, C., Varangot, M., Barrios, E. and Osinaga, E. (2006), UDP-N-acetyl-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 6 (ppGalNAc-T6) mRNA as a potential new marker for detection of bone marrow-disseminated breast cancer cells. Int. J. Cancer, 119: 1383–1388. doi: 10.1002/ijc.21959

Author Information

  1. 1

    Laboratorio de Oncología Básica y Biología Molecular, Dpto. de Bioquímica, Facultad de Medicina, Universidad de la República, Montevideo, Uruguay

  2. 2

    Servicio de Oncología Clínica, Hospital de Clínicas, Facultad de Medicina, Universidad de la República, Montevideo, Uruguay

  3. 3

    Dpto. de Biofísica, Facultad de Medicina, Universidad de la República, Montevideo, Uruguay

  1. †

    Unité de Chimie Organique URA CNRS 2128, Institut Pasteur, Paris, France

  1. ‡

    Fax: 598-29249563

*Dpto. de Bioquímica, Facultad de Medicina, Av. Gral. Flores 2125, Montevideo CP 11800, Uruguay

Publication History

  1. Issue published online: 7 JUL 2006
  2. Article first published online: 4 APR 2006
  3. Manuscript Accepted: 7 FEB 2006
  4. Manuscript Received: 16 JUL 2005

Funded by

  • Comisión Honoraria de Lucha Contra el Cáncer (Uruguay)

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (146K)

References

  • 1
    Pantel K, Muller V, Auer M, Nusser N, Harbeck N, Braun S. Detection and clinical implications of early systemic tumor cell dissemination in breast cancer. Clin Cancer Res 2003; 9: 6326–34.
  • 2
    Pantel K; Brakenhoff RH. Dissecting the metastatic cascade. Nat Rev Cancer 2004; 4: 448–56.
  • 3
    Cote R, Rosen P, Lesser M, Old L, Osborne M. Prediction of early relapse in patients with operable breast cancer by detection of occult bone marrow micrometastases. J Clin Oncol 1991; 9: 1749–56.
  • 4
    Braun S, Pantel K, Müller P, Janni W, Hepp F, Kentenich CRM, Gastroph S, Wischnik A, Dimpfl T, Kindermann G, Riethmüller G, Schlimok G. Cytokeratin positive cells in the bone marrow and survival of patients with stage I, II, or III breast cancer. N Engl J Med 2000; 342: 525–33.
  • 5
    Gerber B, Krause A, Müller H, Richter D, Reimer T, Makovitzky J, Herrnring C, Jeschke U, Kundt G, Friese K. Simultaneous immunohistochemical detection of tumor cells in lymph nodes and bone marrow aspirates in breast cancer and its correlation with other prognostic factors. J Clin Oncol 2001; 19: 960–71.
  • 6
    Wiedswang G, Borgen E, Karesen R, Kvalheim G, Nesland J, Qvist H, Schlichting E, Sauer T, Janbu J, Harbitz T, Naume B. Detection of isolated tumor cells in bone marrow is an independent prognostic factor in breast cancer. J Clin Oncol 2003; 21: 3469–78.
  • 7
    Cristofanilli M, Hayes DF, Budd GT, Ellis MJ, Stopeck A, Reuben JM, Doyle GV, Matera J, Allard WJ, Miller MC, Fritsche HA, Hortobagyi GN, et al. Circulating tumor cells: a novel prognostic factor for newly diagnosed metastatic breast cancer. J Clin Oncol 2005; 23: 1420–30.
  • 8
    Janni W, Rack B, Schindlbeck C, Strobl B, Rjosk D, Braun S, Sommer H, Pantel K, Gerber B, Friese K. The persistence of isolated tumor cells in bone marrow from patients with breast carcinoma predicts an increased risk for recurrence. Cancer 2005; 103: 884–91.
    Direct Link:
  • 9
    Ring A, Smith IE, Dowsett M. Circulating tumour cells in breast cancer. Lancet Oncol 2004; 5: 79–88.
  • 10
    Moscinski LC, Trudeau WL, Fields KK, Elfenbein GJ. High-sensitivity detection of minimal residual breast carcinoma using the polymerase chain reaction and primers for cytokeratin 19. Diagn Mol Pathol 1996; 5: 173–80.
  • 11
    Gerhard M, Juhl H, Kalthoff H, Schreiber H, Wagener C, Neumaier M. Specific detection of carcinoembryonic antigen-expressing tumor cells in bone marrow aspirates by polymerase chain reaction. J Clin Oncol 1994; 12: 725–9.
  • 12
    Reinholz MM, Nibbe A, Jonart LM, Kitzmann K, Suman VJ, Ingle JN, Houghton R, Zehentner B, Roche PC, Lingle WL. Evaluation of a panel of tumor markers for molecular detection of circulating cancer cells in women with suspected breast cancer. Clin Cancer Res 2005; 11: 3722–32.
  • 13
    Soria JC, Gauthier LR, Raymond E, Granotier C, Morat L, Armand JP, Boussin FD, Sabatier L. Molecular detection of telomerase-positive circulating epithelial cells in metastatic breast cancer patients. Clin Cancer Res 1999; 5: 971–5.
  • 14
    Berois N, Varangot M, Sóñora C, Zarantonelli L, Pressa C, Laviña R, Rodríguez JL, Delgado F, Porchet N, Aubert JP, Osinaga E. Detection of bone marrow-disseminated breast cancer cells using a RT-PCR assay of MUC5B mRNA. Int J Cancer 2003; 103: 550–5.
    Direct Link:
  • 15
    Baldus SE, Engelmann K, Hanisch FG. MUC1 and the MUCs: a family of human mucins with impact in cancer biology. Crit Rev Clin Lab Sci 2004; 41: 189–231.
  • 16
    Springer GF. Immunoreactive T and Tn epitopes in cancer diagnosis, prognosis, and immunotherapy. J Mol Med 1997; 75: 594–602.
  • 17
    Breton C, Mucha J, Jeanneau C. Structural and functional features of glycosyltransferases. Biochimie 2001; 83: 713–18.
  • 18
    Machida E, Nakayama J, Amano J, Fukuda M. Clinicopathological significance of core 2 β1,6-N-acetylglucosaminyltransferase messenger RNA expressed in the pulmonary adenocarcinoma determined by in situ hybridization. Cancer Res 2001; 61: 2226–31.
  • 19
    Murata K, Miyoshi E, Kameyama M, Ishikawa O, Kabuto T, Sasaki Y, Hiratsuka M, Ohigashi H, Ishiguro S, Ito S, Honda H, Takemura F, et al. Expression of N-acetylglucosaminyltransferase V in colorectal cancer correlates with metastasis and poor prognosis. Clin Cancer Res 2000; 6: 1772–7.
  • 20
    Schneider F, Kemmner W, Haensch W, Franke G, Gretschel S, Karsten U, Schlag PM. Overexpression of sialyltransferase CMP-sialic acid:Galβ1,3GalNAc-R α6-sialyltransferase is related to poor patient survival in human colorectal carcinomas. Cancer Res 2001; 61: 4605–11.
  • 21
    D'Arrigo A, Belluco C, Ambrosi A, Digito M, Esposito G, Bertola A, Fabris M, Nofrate V, Mammano E, Leon A, Nitti D, Lise M. Metastatic transcriptional pattern revealed by gene expression profiling in primary colorectal carcinoma. Int J Cancer 2005; 115: 256–62.
    Direct Link:
  • 22
    Shimizu F, Nakayama J, Ishizone S, Zhang MX, Kawakubo M, Ota H, Sugiyama A, Kawasaki S, Fukuda M, Katsuyama T. Usefulness of the real-time reverse transcription-polymerase chain reaction assay targeted to α1,4-N-acetylglucosaminyltransferase for the detection of gastric cancer. Lab Invest 2003; 83: 187–97.
  • 23
    Cheung IY, Lo Piccolo MS, Kushner BH, Kramer K, Cheung NK. Quantitation of GD2 synthase mRNA by real-time reverse transcriptase polymerase chain reaction: clinical utility in evaluating adjuvant therapy in neuroblastoma. J Clin Oncol 2003; 21: 1087–93.
  • 24
    Brockhausen I. Pathways of O-glycan biosynthesis in cancer cells. Biochim Biophys Acta 1999; 1473: 67–95.
  • 25
    Burchell JM, Mungul A, Taylor-Papadimitriou J. O-linked glycosylation in the mammary gland: changes that occur during malignancy. J Mammary Gland Biol Neoplasia 2001; 6: 355–64.
  • 26
    Ten Hagen K, Fritz T, Tabak, L. All in the family: the UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferases. Glycobiology 2003; 13: 1R–16R.
  • 27
    Berois N, Varangot M, Aizen B, Estrugo R, Zarantonelli L, Fernández P, Krygier G, Simonet F, Barrios E, Musé I, Osinaga E. Molecular detection of cancer cells in bone marrow and peripheral blood of patients with operable breast cancer. Comparison of CK19, MUC1 and CEA using RT-PCR. Eur J Cancer 2000; 36: 717–23.
  • 28
    Kaplan EL, Meier P. Non-parametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457–81.
  • 29
    Bennett EP, Hassan H, Mandel U, Hollingsworth MA, Akisawa N, Ikematsu Y, Merkx G, van Kessel AG, Olofsson S, Clausen H. Cloning and characterization of a close homologue of human UDP-N-acetyl-α-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase-T3, designated GalNAc-T6. Evidence for genetic but not functional redundancy. J Biol Chem 1999; 274: 25362–70.
  • 30
    Berois N, Mazal D, Ubillos L, Trajtenberg F, Nicolas A, Sastre-Garau X, Magdelenat H, Osinaga E. UDP-N-acetyl-α-D-galactosamine: polypeptide N-acetylgalactosaminyl transferase-6 as a new immunohistochemical breast cancer marker. J Histochem Cytochem 2006; 64: 317–28.
  • 31
    Nomoto M, Izumi H, Ise T, Kato K, Takano H, Nagatani G, Shibao K, Ohta R, Imamura T, Kuwano M, Matsuo K, Yamada Y, et al. Structural basis for the regulation of UDP-N-acetyl-α-D-galactosamine: polypeptide N-acetylgalactosaminyl transferase-3 gene expression in adenocarcinoma cells. Cancer Res 1999; 59: 6214–22.
  • 32
    Braun S, Naume B. Circulating and disseminated tumor cells. J Clin Oncol 2005; 23: 1623–6.
  • 33
    Klein CA, Seidl S, Petat-Dutter K, Offner S, Geigl JB, Schmidt-Kittler O, Wendler N, Passlick B, Huber RM, Schlimok G, Baeuerle PA, Riethmuller G. Combined transcriptome and genome analysis of single micrometastatic cells. Nat Biotechnol 2002; 20: 387–92.
  • 34
    Schmidt-Kittler O, Ragg T, Daskalakis A, Granzow M, Ahr A, Blankenstein TJ, Kaufmann M, Diebold J, Arnholdt H, Muller P, Bischoff J, Harich D, et al. From latent disseminated cells to overt metastasis: genetic analysis of systemic breast cancer progression. Proc Natl Acad Sci USA 2003; 100: 7737–42.
  • 35
    Smirnov DA, Zweitzig DR, Foulk BW, Miller MC, Doyle GV, Pienta KJ, Meropol NJ, Weiner LM, Cohen SJ, Moreno JG, Connelly MC, Terstappen LW, et al. Global gene expression profiling of circulating tumor cells. Cancer Res 2005; 65: 4993–7.
  • 36
    Cristofanilli M, Budd GT, Ellis MJ, Stopeck A, Matera J, Miller MC, Reuben JM, Doyle GV, Allard WJ, Terstappen LW, Hayes DF. Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N Engl J Med 2004; 351: 781–91.
  • 37
    Julien S, Lagadec C, Krzewinski-Recchi MA, Courtand G, Le Bourhis X, Delannoy P. Stable expression of sialyl-Tn antigen in T47-D cells induces a decrease of cell adhesion and an increase of cell migration. Breast Cancer Res Treat 2005; 90: 77–84.
  • 38
    Marcos NT, Cruz A, Silva F, Almeida R, David L, Mandel U, Clausen H, Von Mensdorff-Pouilly S, Reis CA. Polypeptide GalNAc-transferases, ST6GalNAc-transferase I, and ST3Gal-transferase I expression in gastric carcinoma cell lines. J Histochem Cytochem 2003; 51: 761–71.
  • 39
    Yamamoto S, Nakamori S, Tsujie M, Takahashi Y, Nagano H, Dono K, Umeshita K, Sakon M, Tomita Y, Hoshida Y, Aozasa K, Kohno K, et al. Expression of uridine diphosphate N-acetyl-α-D-galactosamine: polypeptide N-acetylgalactosaminyl transferase 3 in adenocarcinoma of the pancreas. Pathobiology 2004; 71: 12–18.
  • 40
    Shibao K, Izumi H, Nakayama Y, Ohta R, Nagata N, Nomoto M, Matsuo K, Yamada Y, Kitazato K, Itoh H, Kohno K. Expression of UDP-N-acetyl-α-D-galactosamine-polypeptide galNAc N-acetylgalactosaminyl transferase-3 in relation to differentiation and prognosis in patients with colorectal carcinoma. Cancer 2002; 94: 1939–46.
    Direct Link:
  • 41
    Miyahara N, Shoda J, Kawamoto T, Furukawa M, Ueda T, Todoroki T, Tanaka N, Matsuo K, Yamada Y, Kohno K, Irimura T. Expression of UDP-N-acetyl-α-D-galactosamine-polypeptide N-acetylgalactosaminyl transferase isozyme 3 in the subserosal layer correlates with postsurgical survival of pathological tumor stage 2 carcinoma of the gallbladder. Clin Cancer Res 2004; 10: 2090–9.
View Full Article (HTML) Get PDF (146K)